Kamala presented her poster:
Serum FAS, Ferritin, Igfbp2, sTNFR2 As Markers for Tracking Mucocutaneous and Musculoskeletal Flares in SLE Patients
Kamala Vanarsa, Samar Soliman, Aubrey Swilling, Joan T. Merrill and Chandra Mohan.
Sanam presented her poster:
Unbiased Screening of Urinary Protein Biomarkers for Glomerular Filtration Rate Normalization
Sanam Soomro, Samantha Stanley, Ramesh Saxena, Michelle Petri and Chandra Mohan.
Oral Presentations:
Serum LTB4, HODE13 and PLA2G7 as biomarkers of cardiovascular disease in SLE.
S. Baig, H. Ding, M. McMahon and C. Mohan.
Hemopexin deficiency prevents joint injury following collagen antibody-induced arthritis.
S. Baig, Y. Du, Q. Ling, L. Paglicawan, K. Vanarsa, and C. Mohan.
Identification of protein biomarkers in cerebrospinal fluid (CSF) of Neuro Psychiatric SLE (NPSLE) patients using SOMA scan assay.
K. Vanarsa, J. Hanly, C.C. Mok and C. Mohan.
Poster Presentations:
Hemopexin deficiency prevents joint injury following collagen antibody-induced arthritis.
S. Baig, Y. Du, Q. Ling, L. Paglicawan, K. Vanarsa, and C. Mohan.
Serum LTB4, HODE13 and PLA2G7 as biomarkers of cardiovascular disease in SLE.
S. Baig, H. Ding, M. McMahon and C. Mohan.
Targeting FAAH in hematological and non-hematological cancers.
T. Doan, J. Sun, J. Henderson, Y. Du and C. Mohan.
Assessing the disease specificity of urinary PF4 for active lupus nephritis.
S. Gokaraju, A. Haque, K. Vanarsa, S. Soliman, R. Saxena, and C. Mohan.
Salivary biomarkers in SLE.
S. Gotewal, S. Soomro, U. Akbar, R. Saxena, M. Petri and C. Mohan.
Serum IGFBP2, IGFBP4, and sTNFR2 are predictive of concurrent clinical and histological nephritis in SLE.
A. Haque, S. Soliman, K. Vanarsa, S. Stanley, R. Saxena and C. Mohan.
ALCAM and VCAM-1 as potential urinary biomarkers in Caucasian lupus patients.
D. Habazi, K. Vanarsa, S. Stanley, S. Gokaraju, H. Ding, I. Parodis, I. Gunnarsson and C. Mohan.
Epigallocatechin-3-Gallate suppresses neutrophil accumulation and the IL-1 beta pathway in a transgenic zebrafish model of inflammation.
T. Nguyen, B. Payan, M. Bondesson and C. Mohan.
Epigallocatechin-3-gallate prevents Non-alcoholic fatty liver disease by modulating liver function, lipid profiles and M1/M2 macrophage polarization.
L. Paglicawan, Y. Du, S. Soomro, S. Baig, K. Vanarsa and C. Mohan.
Epigallocatechin-3-Gallate suppresses neutrophil accumulation and the IL-1 beta pathway in a transgenic zebrafish model of inflammation.
T. Nguyen, B. Payan, M. Bondesson and C. Mohan.
Aptamer-based screening of cerebrospinal fluid for protein biomarkers of multiple sclerosis.
S. Soomro, S. Hughes, B. Greenberg, J. Hanly and C. Mohan.
Quantitative screening of active renal SLE patients’ urine for protein biomarkers using kiloplexed glass slide arrays.
S. Soomro, M. Attia, M. Petri and C. Mohan.
Identification of Low-Abundance Urinary Biomarkers for Lupus Nephritis Utilizing Electrochemiluminescence-Based Multiplexed Assays.
S. Stanley, C. Mok, K. Vanarsa, D. Habazi, R. Saxena and C. Mohan.
Pro-inflammatory bradykinin metabolites are upregulated in SLE and rheumatoid arthritis.
K. Vanarsa, J. Henderson, Q. Ling, S. Soomro, R. Saxena, C. Putterman, I. Blanco and C. Mohan.
Identification of protein biomarkers in cerebrospinal fluid (CSF) of Neuro Psychiatric SLE (NPSLE) patients using SOMA scan assay.
K. Vanarsa, J. Hanly, C.C. Mok and C. Mohan.
Targeting fatty acid amide hydrolase (FAAH) in diffuse large B-cell lymphoma (DLBCL).
C.R. Woods, J. Sun, J. Henderson and C. Mohan.
